Fingerprint
Dive into the research topics of 'Disparities in PI3K/mTOR inhibitor use, toxicities, and outcomes among patients with metastatic breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Disparities in PI3K/mTOR inhibitor use, toxicities, and outcomes among patients with metastatic breast cancer
Claire Sathe, Melissa K. Accordino, David DeStephano, Mansi Shah, Jason D. Wright, Dawn L. Hershman
Research output: Contribution to journal › Article › peer-review